The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

2017-05-24

Additional Metadata
Persistent URL	doi.org/10.1007/s00259-017-3707-3, hdl.handle.net/1765/100235
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Chiesa, C., Sjögreen-Gleisner, K., Flux, G., Gear, J., Walrand, S., Bacher, K., Eberlein, U., Visser, E.P., Chouin, N., Ljungberg, M., Bardiès, M., Lassmann, M., Strigari, L.& Konijnenberg, M. (2017). The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. European Journal of Nuclear Medicine and Molecular Imaging, 1–4.https://doi.org/10.1007/s00259-017-3707-3

Publication